NewslettersCell Therapy NewsLysophosphatidic Acid Modulates CD8 T Cell Immunosurveillance and Metabolism To Impair Anti-Tumor ImmunityBy Jamie Kang - June 5, 20230180Lysophosphatidic acid receptor signaling by CD8 T cells promoted tolerogenic states via metabolic reprogramming and potentiating exhaustive-like differentiation to modulate anti-tumor immunity.[Nature Communications]Full Article